Ligence Heart vs iCAC Device

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 68/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Ligence
VS
by Bunkerhill Health

AI Verdict

Ligence Heart automates the analysis and reporting of 2D transthoracic echocardiography, enhancing diagnostic efficiency for cardiologists and sonographers by assessing heart function and structure. In contrast, Bunkerhill Health's iCAC Device uses AI to detect and quantify coronary artery calcium from routine chest CT scans, aiding radiologists in early cardiovascular disease detection. While both are cardiology AI tools, they address different diagnostic needs using distinct imaging modalities, making them complementary rather than direct competitors.

Choose Ligence Heart if…

Choose Ligence Heart if your primary need is to streamline and enhance the diagnostic workflow for 2D transthoracic echocardiography. This tool is ideal for cardiology departments and sonography labs seeking to automate complex measurements, improve reporting accuracy, and accelerate the identification of various heart diseases directly from echo images. It empowers cardiologists and sonographers with AI-driven insights for comprehensive cardiac function and structural analysis.

View Ligence Heart →

Choose iCAC Device if…

Choose iCAC Device if your goal is to opportunistically identify and quantify coronary artery calcium from routine, non-contrast chest CT scans already performed for other indications. This solution is best suited for healthcare systems looking to enhance early cardiovascular disease detection by leveraging existing imaging data, providing radiologists with adjunctive information on cardiovascular risk without requiring additional dedicated scans. It helps identify patients at risk who might otherwise be missed.

View iCAC Device →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Ligence Heart iCAC Device
Pricing Contact-for-pricing Contact for pricing
Deployment Cloud-based; on-premise; hybrid Software as a Medical Device (SaMD), integrates with PACS or DICOM router. Cloud-based (via Carebricks platform).
FDA Status 1 AI-estimated 1 AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Ligence Heart iCAC Device
Name Ligence Heart iCAC Device
Company Ligence Bunkerhill Health
Primary Modality Analyzed 2D transthoracic echocardiography Routine, non-contrast, non-gated chest CT scans
Core Functionality Automated analysis and reporting of echocardiography, including view classification, heart phase prediction, measurements (Area, Distance, Doppler, Volume, Strain, Spectral/Tissue Doppler), and disease recognition (Heart failure, cardiomyopathy, pulmonary hypertension, valvular heart diseases). Detects and quantifies coronary artery calcium (CAC) using deep-learning algorithms, provides visual and quantitative estimates (Agatston units), and supports opportunistic identification of CAC.
Integration Capabilities PACS, EHR, RIS PACS, DICOM router, EHRs (via the Carebricks platform)

Videos

Demos, reviews, and walkthroughs featuring Ligence Heart and iCAC Device.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Ligence Heart is an AI-powered platform that automates the analysis and reporting of 2D transthoracic echocardiography, enhancing diagnostic efficiency and accuracy for cardiologists and sonographers. In contrast, Bunkerhill Health's iCAC Device is an FDA-cleared AI algorithm that detects and quantifies coronary artery calcium from routine, non-contrast, non-gated chest CT scans, aiding in early cardiovascular disease detection.
Ligence Heart is designed to enhance diagnostic efficiency and accuracy for cardiologists and sonographers. The iCAC Device provides adjunctive information to radiologists for the estimation of coronary artery calcium.
Ligence Heart offers automated recognition of echocardiography imaging data, view classification, heart phase prediction, calculation of measurements (Area, Distance, Doppler, Volume, strain, Spectral and Tissue Doppler), and report generation, including disease recognition for conditions like heart failure and valvular heart diseases. The iCAC Device estimates the presence and quantity of coronary artery calcium (CAC) in Agatston units, providing both visual representation and four-category quantitative estimates of CAC burden.
Ligence Heart integrates with existing systems such as PACS, EHR, and RIS. The iCAC Device, as a Software as a Medical Device (SaMD), integrates with PACS or DICOM routers and can integrate with EHRs via the Carebricks platform.
AI Tool Finder
AI-powered search. Results may not be comprehensive.